Stay updated on CT-P16 vs Avastin in Lung Cancer Clinical Trial
Sign up to get notified when there's something new on the CT-P16 vs Avastin in Lung Cancer Clinical Trial page.
Latest updates to the CT-P16 vs Avastin in Lung Cancer Clinical Trial page
- Check5 days agoChange DetectedThe website has been updated from version 2.14.0 to 2.14.1.SummaryDifference0.1%
- Check12 days agoChange DetectedThe website has updated the intervention type to 'Verified 2022-08 by Celltrion' with a new active status, while also revising the version from v2.13.3 to v2.14.0.SummaryDifference1%
- Check19 days agoNo Change Detected
- Check27 days agoNo Change Detected
- Check34 days agoNo Change Detected
- Check41 days agoChange DetectedThe website has been updated from version 2.13.2 to 2.13.3.SummaryDifference0.1%
- Check48 days agoChange DetectedThe website has updated the contact details section for the study, clarifying that it now provides information for individuals who can answer questions about joining the study and includes a reference to the Contacts and Locations section.SummaryDifference5%
- Check63 days agoChange DetectedThe website has added new features, while several detailed data fields and options for downloading study information have been removed.SummaryDifference7%
- Check70 days agoChange DetectedSeveral key health-related links have been removed, including resources from MedlinePlus and NIH, which may impact access to information on genetics and lung cancer.SummaryDifference0.7%
Stay in the know with updates to CT-P16 vs Avastin in Lung Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CT-P16 vs Avastin in Lung Cancer Clinical Trial page.